EIR Grifols Therapeutics Apr 2014

Mihaly Ligmond FDA$595.00 - Available Now

FDA investigators audited the Grifols Therapeutics - Clayton, NC, United States facility and issued inspectional observation (via FDA 483) on 01 Apr 2014.

Product details

  • Category:
  • Inspection end: 01 Apr 2014
  • Location: Clayton, United States
  • FEI: 1050373
Add To Cart